Document: Terms of reference for the European Medicines Agency and the United States Food and Drugs Administration cluster on orphan medicinal products-2026/7/17

Document: Terms of reference for European Medicines Agency and United States Food and Drug Admnistration oncology early-dialogue cluster-2026/7/17

Document: Terms of Reference for the Non-Clinical Oncology European Medicines Agency and United States Food and Drug Administration Cluster-2026/7/17

Document: Neuroscience Cluster – Terms of Reference-2026/7/17

Document: Terms of reference for the European Medicines Agency and United States Food and Drugs Administration cardiovascular cluster-2026/7/17

Document: Dual chamber leadless pacemaker - Notified Bodfy 123 - 28/03/2024 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)-2026/7/17

Document: List of clinical evaluation consultation procedure (CECP) opinions issued for medical devices awaiting finalisation of conformity assessment-2026/7/17

Document: Terms of reference for the European Medicines Agency, Health Canada and United States Food and Drug Administration cluster on blood products-2026/7/17

Document: Biostatistics cluster – Terms of Reference-2026/7/17

Document: Antivirals cluster – Terms of Reference-2026/7/17